Key Statistics
Market Cap$1.53B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.32
52W High$14.39
52W Low$4.85
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+5.38%
3 Month+5.11%
1 Year+91.96%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$89.40M
Liabilities$6.86M
Net Income$29.07M loss
About
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious neurology-mediated conditions. The company is headquartered in New Haven, Connecticut.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze TRVI with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.